abstract |
A nucleic acid nanostructure for in vivo drug delivery is provided. The present disclosure, according to an aspect, provides a nucleic acid nanostructure subsaturated with a polyamine polymer. The present disclosure also includes, according to an aspect, a first nucleic acid nanostructure bound to a second nucleic acid nanostructure by a pH-sensitive contact portion, thereby comprising a nanocompartment having an inner compartment having an outer surface and an inner surface. Also provided is a nucleic acid nanocapsule forming a capsule. [Selection diagram] None |